Arena Pharmaceuticals Inc., of San Diego, reported that for the first quarter ending March 31, approximately 77,000 prescriptions for Belviq (lorcaserin HCl) were filled, according to IMS Health, representing growth of approximately 31 percent in total prescriptions as compared to the previous quarter.